INVESTOR NOTICE: Lundin Law PC Announces Investigation Of Immunomedics Inc. And Advises Investors With Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)-- Lundin Law PC announces it is investigating claims against Immunomedics Inc. (“Immunomedics” or the “Company”) (Nasdaq: IMMU) concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by Immunomedics were false and misleading and/or failed to disclose material information regarding the Company’s financial performance.

To participate in this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at [email protected].

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on a June 2, 2016, media report that the American Society of Clinical Oncology ("ASCO") had removed a scheduled presentation by Immunomedics regarding the Company's IMMU-132 breast cancer drug from ASCO's annual meeting.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160620006062/en/

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]

Source: Lundin Law PC

You May Also Be Interested In

• NorthStar Appoints Peter Pfreundschuh to Board of Managers
• Twentyfour-Seven Pioneers Financial Freedom for Trafficking Victims by Teaming Up With Consumer & Advocate Organizations
• INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Live Nation Entertainment, Inc. and Encourages Investors with Losses to Contact the Firm